SNHG1 and posterior cortical atrophy: More importantly, SNHG1 is intricately linked to cancer and is abnormally expressed in various cancers, including hepatocellular carcinoma (HCC) [16], breast cancer (BC) [19], bladder cancer (BLC) [20], esophageal squamous cell carcinoma (ESCC) [23], prostate cancer (PCa) [27], osteosarcoma (OS) [28], non-small cell lung cancer (NSCLC) [33], colorectal cancer (CRC) [38], gastric cancer (GC) [40], and acute myeloid leukemia (AML) [48].